Zejula 100mg (Niraparib Capsule) 100mg

ZEJULA 100MG capsules contain niraparib, a prescription medication used to help prevent cancer progression. This oral therapy is designed for maintenance treatment in certain conditions. Niraparib 100mg capsules support targeted cancer care with convenient at-home administration.

Strength

100mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Takeda Pharma A/S

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Niraparib is primarily used for maintenance therapy in adults with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response to platinum-based chemotherapy. It is also indicated for certain patients with advanced ovarian cancer following first-line platinum-based chemotherapy. This medication helps delay cancer progression by targeting specific DNA repair pathways in cancer cells.

Side Effects

Niraparib works by inhibiting PARP enzymes, which are involved in repairing damaged DNA in cells. By blocking these enzymes, niraparib can help prevent cancer cells from repairing their DNA, leading to reduced tumor growth. Patients may experience improved disease stability during treatment.

Precautions & Warnings

Store niraparib capsules at room temperature away from moisture and heat. Keep the medication in its original packaging until ready to use. Handle with care and avoid opening capsules to prevent accidental exposure. Always follow your healthcare provider’s instructions for safe storage and disposal.

Avoid Interactions

Niraparib may interact with other medications, including strong CYP3A inhibitors or inducers, which can affect its effectiveness. Grapefruit and grapefruit juice may also interact with niraparib. Discuss all current medications and supplements with your healthcare provider before starting treatment to minimize potential risks.

Frequently Asked Questions

Niraparib is used as a maintenance treatment for certain types of ovarian cancer in adults who have responded to platinum-based chemotherapy.

Store niraparib capsules at room temperature, away from moisture and heat, in their original packaging.

Consult your healthcare provider before taking niraparib with other medications, as interactions may occur.

If you miss a dose, take it as soon as you remember unless it is close to your next scheduled dose. Do not double up on doses.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.